| Table 4: Clinical and pathologic characteristics of the 10 tumours diagnosed during surveillance and of 3 other relevant conditions found during surveillance |
| Risk category; patient's age at diagnosis, yr |
Pathologic description |
Time to diagnosis, mo |
Nodal status |
Tumour size, cm |
Grade |
Mode of diagnosis |
|
TUMOURS |
|
High (n = 5) |
| 54 |
Infiltrating ductal carcinoma (IDC) |
27 |
Negative |
1.5 |
Intermediate |
CBE |
| 81 |
Infiltrating lobular carcinoma (ILC) |
29 |
Negative |
1.0 |
Intermediate |
CBE |
| 49* |
Ductal carcinoma in situ (DCIS) |
51 |
NA |
NA |
Low |
Mammography |
| 52* |
IDC |
44 |
Negative |
1.0 |
Intermediate |
BSE |
| 42* |
IDC |
13 |
Negative |
1.5 |
High |
BSE |
|
Moderate (n = 2) |
| 41* |
IDC |
20 |
Negative |
1.5 |
High |
BSE |
| 50* |
IDC |
45 |
Negative |
1.0 |
Not stated |
BSE |
|
Slightly increased (n = 3) |
| 41 |
DCIS |
12 |
NA |
NA |
High |
Mammography |
| 52 |
DCIS |
31 |
NA |
NA |
Low |
Mammography |
| 48 |
Tubular carcinoma |
14 |
Negative |
1.5 |
Low |
Mammography |
|
OTHER RELEVANT CONDITIONS |
|
High (n = 2) |
| 44* |
Lobular carcinoma in situ (LCIS) |
24 |
NA |
NA |
NA |
CBE |
| 21* |
Phylloides tumour |
24 |
NA |
NA |
NA |
CBE |
|
Moderate (n = 1) |
| 39* |
LCIS |
14 |
NA |
NA |
NA |
BSE |
|
*Patients with a family history of breast cancer. |
